DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
dc.contributor.author | Inel, TY | |
dc.contributor.author | Kocaer, SB | |
dc.contributor.author | Erez, Y | |
dc.contributor.author | Gulle, S | |
dc.contributor.author | Karakas, A | |
dc.contributor.author | Avsar, AK | |
dc.contributor.author | Uslu, S | |
dc.contributor.author | Can, G | |
dc.contributor.author | Sari, I | |
dc.contributor.author | Birlik, M | |
dc.contributor.author | Dalkiliç, E | |
dc.contributor.author | Pehlivan, Y | |
dc.contributor.author | Akar, S | |
dc.contributor.author | Goker, B | |
dc.contributor.author | Cetin, GY | |
dc.contributor.author | Haznedaroglu, S | |
dc.contributor.author | Yavuz, S | |
dc.contributor.author | Pirildar, T | |
dc.contributor.author | Direskeneli, H | |
dc.contributor.author | Akkoc, N | |
dc.contributor.author | Onen, F | |
dc.date.accessioned | 2025-04-10T10:36:50Z | |
dc.date.available | 2025-04-10T10:36:50Z | |
dc.identifier.e-issn | 1468-2060 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/42646 | |
dc.language.iso | English | |
dc.title | DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO | |
dc.type | Meeting Abstract |